Zotarolimus- and Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease - ZoMaxx I


The goal of the trial was to evaluate percutaneous coronary intervention (PCI) using the ZoMaxx zotarolimus-eluting stent (ZES) compared with the Taxus paclitaxel-eluting stent (PES) among patients with single de novo coronary lesions.

The ZoMaxx stent is a novel platform composed of a tri-layer of stainless-steel and tantalum.